Furthermore, the analysis of a cohort of 112 CMS2 CRC patients showed a significant negative correlation between ZEB2 expression and RFS probability (Fig. 6h, i), suggesting that ZEB2 is a putative prognostic factor that could be relevant in cancer patients affected by obesity. Here, ZEB2 is linked to obesity due to melanocortin 4 receptor deficiency.